Mealey's PI/Product Liability - Avandia MDL Judge Says Ark. 'Illegal Extraction' Case Mooted By State's Settlement

Mealey's PI/Product Liability - Avandia MDL Judge Says Ark. 'Illegal Extraction' Case Mooted By State's Settlement

PHILADELPHIA - A private Arkansas "illegal extraction" claim against GlaxoSmithKline PLC (GSK) for its marketing of the Avandia diabetes drugs is moot because the state attorney general has already settled identical claims, a Pennsylvania federal judge ruled April 10 in granting the defendant summary judgment (In Re: Avandia Marketing, Sales Practices and Products Liability Litigation, MDL Docket No. 1871, No. 07-md-1871, Greg Bowerman v. GlaxoSmithKline LLC, No. 12-3463, E.D. Pa.).

Find full version on lexis Advance®
Access this news story on lexis.com®